4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Click chemistry to functionalise peptidomimetics

      , ,   ,
      Tetrahedron Letters
      Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Recent advances in tumor-targeting anticancer drug conjugates.

          Traditional cancer chemotherapy relies on the premise that rapidly proliferating cancer cells are more likely to be a killed by cytotoxic agent. In reality, however, cytotoxic agents have very little or no specificity, which leads to systemic toxicity, causing severe undesirable side effects. Therefore, various drug delivery protocols and systems have been explored in the last three decades. Tumor cells overexpress many receptors and biomarkers, which can be used as targets to deliver cytotoxic agents into tumors. In general, a tumor-targeting drug delivery system consists of a tumor recognition moiety and a cytotoxic warhead connected directly or through a suitable linker to form a conjugate. The conjugate, which can be regarded as 'prodrug', should be systemically non-toxic. This means that the linker must be stable in circulation. Upon internalization into the cancer cell the conjugate should be readily cleaved to regenerate the active cytotoxic agent. Tumor-targeting conjugates bearing cytotoxic agents can be classified into several groups based on the type of cancer recognition moieties. This review describes recent advances in tumor-targeting drug conjugates including monoclonal antibodies, polyunsaturated fatty acids, folic acid, hyaluronic acid, and oligopeptides as tumor-targeting moieties.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Peptidomimetics—Tailored Enzyme Inhibitors

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Peptidomimetics for Receptor Ligands?Discovery, Development, and Medical Perspectives

                Bookmark

                Author and article information

                Journal
                Tetrahedron Letters
                Tetrahedron Letters
                Elsevier BV
                00404039
                May 2006
                May 2006
                : 47
                : 22
                : 3697-3700
                Article
                10.1016/j.tetlet.2006.03.149
                9636769a-b0ee-419f-abfe-d2a08206c7be
                © 2006

                http://www.elsevier.com/tdm/userlicense/1.0/

                History

                Comments

                Comment on this article